Highlights From Altria’s 4th-Quarter Earnings Call

MarketBusiness
Feb.08.2023
Company says smokers switching to cheaper options; gives update on innovation

Hannah Hammond of cspdailynews.com

 

High inflation rates in 2022 affected tobacco consumer’s behaviors, discretionary income and spending, Altria said in its fourth-quarter 2022 earnings report.

 

“As a result, our businesses and the industry experienced elevated volume declines, and we observed accelerated share growth in discount cigarettes,” the Richmond, Virginia-based tobacco company said. “Despite these factors, our leading tobacco brands remained resilient, and we continued to observe significant brand loyalty in the tobacco space overall.”

 

Net revenues decreased 2.3% to $6.1 billion in fourth quarter 2022, primarily driven by lower net revenues in the smokeable products segment, Altria said. For the full year 2022, net revenues were down 3.5% to $25.1 billion year-over-year. This was primarily driven by the sale of Altria’s former Ste. Michelle wine business in October 2021, the company said, and lower net revenues in the smokeable products segment.

 

Cigarette Sales Sink

 

Altria’s cigarette sales volume sunk by about 12% in the fourth quarter of 2022. The consumer remains under pressure, Altria’s CEO Billy Gifford said at the company’s Feb. 1 earnings call, which is causing them to smoke fewer cigarettes per day and switch to cheaper brands.

 

Marlboro’s, Altria’s flagship cigarette brand, retail share of the total cigarette category decreased 0.4 share points to 42.5% in the fourth quarter. This was primarily due to increased macroeconomic pressures on the adult tobacco consumer’s disposable income and increased competitive activity, Altria said.

 

However, Marlboro’s share of the premium segment grew to 58.2%, an increase of 0.5% share points.

 

“We are encouraged by Marlboro’s resilient performance as the brand celebrates 50 years of leadership in the cigarette category,” Sal Mancuso, Altria’s CFO, said on the call.

 

Nicotine Pouches Increase Share

 

The U.S. nicotine pouch category grew to 24.4% of the U.S. oral tobacco category in fourth quarter 2022, an increase from the year prior. Altria’s modern oral nicotine (MON) pouch On grew its share 2.5 points versus the prior year to 24%, Altria said. 

 

“This impressive performance was driven by continued increases in brand awareness and adoption by smokers and dippers,” Gifford said. “Additionally, we believe Helix effectively managed On promotional spend as the year progressed and reduced On promotional spend per can by approximately 15% during the second half of the year compared to the first half.”

 

 Altria established Helix Innovations LLC in 2019 to commercialize and distribute On.

 

Innovation Progresses

 

Gifford also highlighted the company’s progress in innovation.

 

“In oral tobacco product development, we are excited to announce we have finalized a new product design, which will provide tobacco consumers more smoke-free options within our portfolio,” he said. “We also began regulatory preparations for the product, and we are encouraged by the initial research results and the response we have received from dippers and nicotine pouch users.”

 

More information on the product will be released at Altria’s investor day in March, he said.

 

Altria has not finalized the design of its heated tobacco capsule product, but the team is making progress, Gifford said. It also announced a strategic partnership with Japan Tobacco in October to eventually bring heated tobacco sticks, made of Ploom-branded devices and Marlboro-branded consumables, to the United States.

 

Juul Devalued

 

E-vapor has been a major contributor to the growth of smoke-free products over the five-year period, Gifford said, although volumes declined by an estimated 1% year-over-year amid considerable regulatory uncertainty, such as the FDA marketing denial order and subsequent temporary stay on Juul products. This cause disruptions for both consumers and retailers, he said.

 

As of Dec. 31, 2022, the estimated fair value of Altria’s investment in Juul was $250 million. This is a significant drop from the initial value of Juul when Altria invested a 35% stake in the company in 2018.

 

In September, when Altria announced it was ending its noncompete agreement with Juul, San Francisco, it said it valued its investment in Juul at $450 million. Juul did not respond back to CSP’s request for comment on its devaluation.

*The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the original author and refrain from forwarding directly from here.

FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
FDA Proposes Foreign Tobacco Factory Registration Rule to Tighten Import Oversight
The FDA has proposed a rule requiring foreign tobacco manufacturers to register facilities and list products before exporting to the U.S. If finalized, the rule could affect overseas OEM/ODM factories, contract manufacturers, specification developers, bulk product makers, and repackaging or relabeling firms. FDA says the proposal would help identify unauthorized imported tobacco products, including e-cigarettes.
Special Report
Jun.26
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
FDA Warns Retailers Over Unauthorized Nicotine Pouches Resembling Candy and Everyday Products
The FDA issued warning letters to eight retailers selling unauthorized nicotine pouches and dissolvable tobacco products resembling candy, breath strips and cough drops. The action highlights rising scrutiny of packaging, youth appeal and accidental ingestion risks, as the agency clarifies enforcement priorities for unauthorized ENDS and nicotine pouch products while maintaining PMTA as the legal market pathway.
Special Report
May.21
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
FDA Grants MRTP Orders for 20 ZYN Nicotine Pouches
The U.S. Food and Drug Administration (FDA) has issued modified risk granted orders to Swedish Match USA for 20 ZYN nicotine pouch products, allowing the already-authorized products to be marketed with a specific claim that using ZYN instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis.
Jul.01
Chinese Disposable Brands OXBAR, LYCO Challenge Vuse and JUUL: Pennsylvania’s Pending List Offers a Glimpse of the Future Legal Vape Market
Chinese Disposable Brands OXBAR, LYCO Challenge Vuse and JUUL: Pennsylvania’s Pending List Offers a Glimpse of the Future Legal Vape Market
Pennsylvania’s June 26 ENDS Pending Certifications list previews the state’s future legal vape market, placing Vuse, JUUL and Logic alongside Chinese-linked disposable brands OXBAR and LYCO. Shaped by PMTA eligibility and state rules, the list shows competition shifting from market share to market access.
Special Report
Jul.06
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
Charlie’s Plans Q3 2026 Pilot of America’s First Age-Gated Flavored Disposable Vape
U.S. vape company Charlie’s Holdings announced plans to pilot its age-gated flavored disposable vape products in hundreds of retail stores during the third quarter of 2026. The company said the products will utilize AI- and blockchain-powered age-verification technology designed to address FDA concerns over youth access and potentially create a new compliance pathway for flavored vape products.
Jun.15
 RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
RFK Jr. Spokesman Resigns Over FDA Authorization of Fruit-Flavored Vapes
Richard Danker, a senior public affairs official in Health Secretary Robert F. Kennedy Jr.’s team, resigned from his role at HHS over the FDA’s recent authorization of fruit-flavored vaping products. In a resignation letter addressed to President Donald Trump, Danker argued that the products could expose minors to nicotine addiction, lung damage, and increased cancer risks, while also conflicting with recent HHS guidance on youth risks associated with flavored nicotine products.
News
May.15